Neoadjuvant chemoimmunotherapy versus chemotherapy for locally advanced esophageal squamous cell carcinoma: a retrospective cohort study.

Li Y, An H, Yang F, Li H, Wang Z, Sun Y, Zhu X, Feng J, Zhang G, Wang H

Open source

DOI
10.1186/s12885-026-16569-z
Published
2026 Jul 18
Container
BMC cancer
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-026-16569-z,
  title = {Neoadjuvant chemoimmunotherapy versus chemotherapy for locally advanced esophageal squamous cell carcinoma: a retrospective cohort study.},
  author = {Li Y and An H and Yang F and Li H and Wang Z and Sun Y and Zhu X and Feng J and Zhang G and Wang H},
  year = {2026},
  journal = {BMC cancer},
  doi = {10.1186/s12885-026-16569-z},
  url = {https://doi.org/10.1186/s12885-026-16569-z}
}

RIS

TY  - JOUR
TI  - Neoadjuvant chemoimmunotherapy versus chemotherapy for locally advanced esophageal squamous cell carcinoma: a retrospective cohort study.
AU  - Li Y
AU  - An H
AU  - Yang F
AU  - Li H
AU  - Wang Z
AU  - Sun Y
AU  - Zhu X
AU  - Feng J
AU  - Zhang G
AU  - Wang H
PY  - 2026
JO  - BMC cancer
DO  - 10.1186/s12885-026-16569-z
UR  - https://doi.org/10.1186/s12885-026-16569-z
ER  - 

APA

Y, L., H, A., F, Y., H, L., Z, W., Y, S., X, Z., J, F., G, Z., & H, W. (2026). Neoadjuvant chemoimmunotherapy versus chemotherapy for locally advanced esophageal squamous cell carcinoma: a retrospective cohort study.. BMC cancer. https://doi.org/10.1186/s12885-026-16569-z

Source records